Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Operating Expenses | 22,785 | 7,415 | 11,363 |
| Operating Income | -22,785 | -7,415 | -11,363 |
| Other Income | 2,197 | 207 | -2,201 |
| Pre-tax Income | -20,588 | -7,208 | -13,564 |
| Net Income Continuous | -20,588 | -7,208 | -13,564 |
| Net Income | $-20,588 | $-7,208 | $-13,564 |
| EPS Basic Total Ops | -5.15 | -1.82 | -3.49 |
| EPS Basic Continuous Ops | -5.15 | -1.82 | -3.49 |
| EPS Diluted Total Ops | -5.15 | -1.82 | -3.49 |
| EPS Diluted Continuous Ops | -5.15 | -1.82 | -3.49 |
| EPS Diluted Before Non-Recurring Items | -5.15 | N/A | N/A |
| EBITDA(a) | $-22,865 | $-7,415 | $-11,253 |